Literature DB >> 11034412

Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes.

Y Luo1, F R Fischer, W W Hancock, M E Dorf.   

Abstract

Astrocytes are specialized cells of the CNS that are implicated in the pathogenesis of multiple sclerosis and experimental allergic encephalomyelitis. In acute and relapsing-remitting experimental allergic encephalomyelitis, the neutrophil chemoattractant CXC chemokines macrophage-inflammatory protein (MIP)-2 and KC are associated with reactive astrocytes in the parenchyma. In vitro treatment of primary astrocyte cultures with nanomolar concentrations of MIP-2 or KC markedly up-regulated expression of the monocyte/T cell chemoattractants monocyte chemoattractant protein-1, inflammatory protein-10, and RANTES by a mechanism that includes stabilization of mRNA. Production of TNF-alpha and IL-6 transcripts were also noted, as was autocrine induction of MIP-2 and KC message. In addition, low levels of MIP-1alpha and MIP-1beta were induced following treatment with MIP-2 or KC. These effects are specific to astrocytes as MIP-2 treatment of microglial cells failed to elicit chemokine production. The astrocyte chemokine receptor for MIP-2 has 2.5 nM affinity for ligand. Astrocytes from CXCR2-deficient mice still respond to KC and MIP-2, indicating the presence of an alternative or novel high affinity receptor for these ligands. We propose that this KC/MIP-2 chemokine cascade may contribute to the persistence of mononuclear cell infiltration in demyelinating autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034412     DOI: 10.4049/jimmunol.165.7.4015

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

3.  Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

Authors:  Dayanidhi Raman; Snjezana-Zaja Milatovic; Dejan Milatovic; Ryan Splittgerber; Guo-Huang Fan; Ann Richmond
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-17       Impact factor: 4.219

4.  T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis.

Authors:  Magdalena J Polanczyk; Richard E Jones; Sandhya Subramanian; Michael Afentoulis; Cathleen Rich; Melissa Zakroczymski; Paul Cooke; Arthur A Vandenbark; Halina Offner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

5.  CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.

Authors:  Nazira El-Hage; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-25       Impact factor: 4.147

6.  Resistance of the brain to Escherichia coli K1 infection depends on MyD88 signaling and the contribution of neutrophils and monocytes.

Authors:  Sandra Ribes; Tommy Regen; Tanja Meister; Simone C Tauber; Sandra Schütze; Alexander Mildner; Matthias Mack; Uwe-Karsten Hanisch; Roland Nau
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

7.  Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.

Authors:  A E Kerstetter; D A Padovani-Claudio; L Bai; R H Miller
Journal:  Exp Neurol       Date:  2009-07-17       Impact factor: 5.330

8.  TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis.

Authors:  Geoffrey Paltser; Xue Jun Liu; Jason Yantha; Shawn Winer; Hubert Tsui; Ping Wu; Yuko Maezawa; Lindsay S Cahill; Christine L Laliberté; Sreeram V Ramagopalan; Gabriele C DeLuca; A Dessa Sadovnick; Igor Astsaturov; George C Ebers; R Mark Henkelman; Michael W Salter; H-Michael Dosch
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

9.  Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

Authors:  Teresa G D'Aversa; Karl O A Yu; Joan W Berman
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

10.  Activation of MIP-2 and MCP-5 Expression in Methylmercury-Exposed Mice and Their Suppression by N-Acetyl-L-Cysteine.

Authors:  Muflihatul Muniroh; Ainun Rahmasari Gumay; Darmawati Ayu Indraswari; Yuriz Bahtiar; Hardian Hardian; Saekhol Bakri; Nani Maharani; Vega Karlowee; Chihaya Koriyama; Megumi Yamamoto
Journal:  Neurotox Res       Date:  2020-02-10       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.